Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique
NCT05788172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2023-11-22
Summary
It is very difficult to quantify menstrual blood loss, the reference method is a tedious one. This is a problem, as it is not conducive to objectively measuring menstrual blood loss and understanding the contribution of menstrual iron loss to iron deficiency anemia. With this study, the investigators aim to investigate iron loss during the menstrual cycle and aim to validate a much simpler technique.
Conditions
- Iron-deficiency
- Menorrhagia
- Anemia
Interventions
- OTHER
-
Iron isotope dilution
Menstrual blood loss will be determined using the iron isotope dilution technique and compared to the amount determined via the alkaline hematin method.
- OTHER
-
Alkaline hematin method
Menstrual blood loss will be determined using the alkaline hematin method and compared to the amount determined via the iron isotope dilution technique.
Sponsors & Collaborators
-
Wageningen University and Research
collaborator OTHER -
Sight and Life Foundation
collaborator UNKNOWN -
Kamuzu University of Health Sciences
collaborator OTHER -
Isabelle Herter-Aeberli
lead OTHER
Principal Investigators
-
Isabelle Herter-Aeberli, PhD · ETH
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2023-06-29
- Completion
- 2023-08-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation
NCT01785407 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Serum Hepcidin Immunoassay - Laboratory to Marketplace
NCT03310736 ·Status: COMPLETED
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Iron Long-Term Labelling Study Switzerland
NCT02979132 ·Status: UNKNOWN ·Phase: NA
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique
NCT07142590 ·Status: RECRUITING ·Phase: NA
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor
NCT03656172 ·Status: COMPLETED
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
Adherence of Iron Succinylate Therapy in Pregnancy
NCT03873571 ·Status: WITHDRAWN
-
Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)
NCT04631679 ·Status: COMPLETED
-
Iron Absorption From Plant Heme Iron
NCT07143890 ·Status: RECRUITING ·Phase: NA
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women
NCT05105438 ·Status: COMPLETED ·Phase: NA
-
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
NCT04205266 ·Status: RECRUITING ·Phase: PHASE4
-
Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.
NCT05742035 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
NCT04636060 ·Status: COMPLETED ·Phase: NA
-
Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage
NCT04505514 ·Status: UNKNOWN ·Phase: PHASE4
-
Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity
NCT02685501 ·Status: UNKNOWN
-
The Optimization of Bioavailability From Iron Supplements: Study 2
NCT02177851 ·Status: COMPLETED ·Phase: NA
-
Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 ·Status: COMPLETED
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3